FindTrial
Sign In

Comparative study of block characterstics of 0.5 percent bupivacaine with 0.5 percent ropivacaine with addition of 2 percent lignocaine with adrenalin in supraclavicular brachial plexus block

Comparative study of block characterstics of supraclavicular brachial plexus block with addition of 2 percent lignocaine with adrenaline to 15 ml of 0.5 percent bupivacaine vs 0.5 percent ropivacaine A Randomised Clinical Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074090
Enrollment
50
Registered
2024-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.5 percent ropivacaine with 2 percent lignocaine adrenaline: 0.5 percent Ropivacaine 15ml and 2 percent lignocaine adrenaline 10ml total of 25 ml will be used Control Intervention1: 0.

Sponsors

Gnanakannan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pts belonging to American Society of Anesthesiologists (ASA) physical status I and II ?Pt scheduled for upper extremity bone surgeries, ?Pt undergoing below the elbow under SCBPB,

Exclusion criteria

Exclusion criteria: Patients who refused to participate, ?with history of allergy to LA drugs ? Patient with evidence of coagulopathy, ? neurological deficit, ? infection at supraclavicular fossa, ? respiratory compromise or difficult sonoanatomy were excluded. ?A consecutive sampling technique was employed.

Design outcomes

Primary

MeasureTime frame
Onset of actionTimepoint: After giving block onset will be assessed every 3 minutes till onset of sensory blockade—

Secondary

MeasureTime frame
Duration of actionTimepoint: Time till patient complains of pain .Patients will be questioned every 30 minutes once for pain sensation postoperatively—

Countries

India

Contacts

Public ContactDr MERLIN SHALINI RUTH

Chettinad hospital and research institute

merlin5shalini@gmail.com9790983957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026